Cite
APA Citation
Lei, J., Zhao, J., Yan, X., Gong, L., Lei, G., & Jiang, T. (n.d.). 56O A randomized, controlled, multicenter phase II trial of camrelizumab combined with albumin-bound paclitaxel and cisplatin as neoadjuvant treatment in resectable stage IIIA and IIIB (T3N2) non-small-cell lung cancer. Immuno-oncology technology, 16, . http://access.bl.uk/ark:/81055/vdc_100172069869.0x000004